Recommendations for Control and Prevention of Human Immunodeficiency Virus (HIV) Infection in Intravenous Drug Users
- 15 May 1989
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 110 (10) , 833-837
- https://doi.org/10.7326/0003-4819-110-10-833
Abstract
Considerable evidence indicates that intravenous drug users are emerging as the group at greatest risk for both acquiring and spreading human immunodeficiency virus (HIV) infection. Thus, all possible methods to control the spread of HIV infection in intravenous drug users should be explored. Key recommendations are that HIV antibody testing of intravenous drug users should be voluntary, because mandatory testing is counterproductive; free distribution of needles and syringes to intravenous drug users should occur only in carefully controlled circumstances to determine its effectiveness in decreasing infection rates; and drug-free and methadone maintenance treatment programs should be available on demand to all intravenous drug users as a means of reducing the spread of HIV infection. At present, the primary strategy for prevention must be education resulting in behavioral change. Education is currently the only definitive means for controlling the spread of HIV infection among intravenous drug users, their sex contacts, and to fetuses.Keywords
This publication has 11 references indexed in Scilit:
- HIV Screening and Counseling for Intravenous Drug Abuse PatientsPublished by American Medical Association (AMA) ,1989
- Discrimination against People with AIDSNew England Journal of Medicine, 1988
- The Epidemiology of Acquired Immunodeficiency Syndrome Among HeterosexualsJAMA, 1988
- The CDC and Abortion in HIV-Positive WomenPublished by American Medical Association (AMA) ,1988
- Prenatal Care and HIV ScreeningJAMA, 1987
- Care of Pregnant Women Infected With Human Immunodeficiency VirusPublished by American Medical Association (AMA) ,1987
- Counseling the HIV-Positive Woman Regarding PregnancyPublished by American Medical Association (AMA) ,1987
- The Prevention of Acquired Immunodeficiency Syndrome in the United StatesJAMA, 1987
- Screening for HIV Infection: Risks, Benefits, and the Burden of ProofLaw, Medicine and Health Care, 1986
- Prevalence of Antibody to Lymphadenopathy-Associated Virus among Drug-Detoxification Patients in New YorkNew England Journal of Medicine, 1984